Efficacy and safety of gemcitabine plus raltitrexed or S-1 versus standard third-line therapies in metastatic colorectal cancer: a retrospective cohort study

Jialong Tao, Yingtian Zhang, Yanjie Wang, Sijia Huang, Wenwen Gao, Liya Dai, Zhengyang Feng, Chenchen Jiao, Yusong Zhang